Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Sales: 2017-2025

Historic Return on Sales for cbdMD (YCBD) over the last 8 years, with Sep 2025 value amounting to -0.11%.

  • cbdMD's Return on Sales rose 8.00% to -0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.11%, marking a year-over-year increase of 8.00%. This contributed to the annual value of -0.11% for FY2025, which is 8.00% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's Return on Sales is -0.11%, which was down 33.67% from -0.08% recorded in Q2 2025.
  • In the past 5 years, cbdMD's Return on Sales registered a high of -0.01% during Q1 2025, and its lowest value of -1.89% during Q3 2022.
  • For the 3-year period, cbdMD's Return on Sales averaged around -0.60%, with its median value being -0.78% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first slumped by 136bps in 2022, then spiked by 97bps in 2023.
  • cbdMD's Return on Sales (Quarterly) stood at -0.76% in 2021, then tumbled by 87bps to -1.64% in 2022, then surged by 81bps to -0.83% in 2023, then surged by 69bps to -0.14% in 2024, then rose by 8bps to -0.11% in 2025.
  • Its Return on Sales stands at -0.11% for Q3 2025, versus -0.08% for Q2 2025 and -0.01% for Q1 2025.